Serial #79447759
LIVE

Serial Number

79447759

Owner

DBV TECHNOLOGIES

Filing Date

Dec 12, 2025

Add to watchlist:

No watchlists yet
View on USPTO

Serial #79447759 Trademark

Serial Number: 79447759

Serial #79447759 is a trademark filed by DBV TECHNOLOGIES on December 12, 2025. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

DBV TECHNOLOGIES (42 trademarks)

177-181 avenue Pierre Brossolette
Montrouge 92120 , FR

Entity Type: 99

Trademark Details

Filing Date

December 12, 2025

Registration Date

Not Registered

Goods & Services

Transdermal patches; skin patches and adhesive skin patches for medical use; transdermal patches and adhesive skin patches for treating, relieving or preventing the development or progression of allergies or immunological disorders; transdermal patches and adhesive skin patches for transdermal administration of pharmaceuticals or medical preparations; epicutaneous systems or patches for cutaneous or epicutaneous administration of medical or pharmaceutical substances for treating allergies or immunological disorders; adhesive patches or adhesive epicutaneous systems for cutaneous or epicutaneous administration of medical or pharmaceutical substances for treating allergies or immunological disorders; occlusive patches or occlusive epicutaneous systems for cutaneous or epicutaneous administration of powdered medical or pharmaceutical substances for treating allergies or immunological disorders; epicutaneous systems or patches containing a powdered preparation for medical or pharmaceutical use for treating allergies or immunological disorders; epicutaneous systems or patches intended for the treatment of allergies or immunological disorders; epicutaneous systems or patches containing allergens or antigens to treat allergies or immunological disorders; medicines against allergies; pharmaceutical preparations for treating allergies; pharmaceutical preparations for treating food allergies; parts for the aforesaid goods; skin compresses intended for receiving, maintaining or containing medical or pharmaceutical substances for the treatment, relief or prevention of allergies or immunological disorders; skin compresses intended for use in medical training; skin compresses for medical use, namely intended for use in training healthcare professionals on the transdermal administration of pharmaceuticals or medical preparations.

Education and training services for consumers and professionals in the field of allergies and immunotherapy: organization of courses, seminars, programs, conferences, congresses, workshops in the field of allergies and immunotherapy; online educational exhibition services featuring interactive displays and exhibits in the field of allergies and immunotherapy; publication of periodicals, books, guides and databases in the field of allergies and immunotherapy; information, advisory and consultancy services relating to the aforementioned services.

Medical devices, apparatus and instruments for cutaneous or epicutaneous administration or delivery, or administration or delivery via a patch, of medical or pharmaceutical substances for the treatment, relief or prevention of allergies or immunological disorders; medical devices, apparatus and instruments sold without medication for the subsequent cutaneous or epicutaneous administration of medical or pharmaceutical substances; dispensers and applicators for compresses, skin patches and occlusion patches for medical use; parts for the aforesaid goods.

Medical services relating to the treatment, relief and prevention of allergies; medical treatment, relief and prevention of allergies, inflammatory, autoimmune and infectious diseases through the administration of medical or pharmaceutical substances, allergens or antigens using patches affixed to the skin of patients; medical consultancy in the field of desensitization to allergies; information, advisory and consultancy services relating to the aforementioned services.

Medical and scientific research services in the field of allergies and immunotherapy; development of scientific methods for cutaneous and epicutaneous immunotherapy; medical and scientific research relating to the treatment, relief and prevention of autoimmune, infectious and inflammatory diseases; medical and scientific research in the fields of allergy treatment and care; allergen drug research services; medical and scientific research services, namely development of methods for treating allergies via contact between allergens and the skin; medical and scientific research services, namely development of methods for treatment and prevention of allergies, autoimmune, infectious and inflammatory diseases by applying patches to the skin of patients; information, advisory and consultancy services relating to the aforementioned services.

Filing History

CORRECTION TRANSACTION RECEIVED FROM IB
May 14, 2026 CRCV
NEW REPRESENTATIVE AT IB RECEIVED
May 7, 2026 NREP
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
May 6, 2026 RFCR
NON-FINAL ACTION WRITTEN
May 5, 2026 CNRT
ASSIGNED TO EXAMINER
Apr 16, 2026 DOCK
APPLICATION FILING RECEIPT MAILED
Apr 10, 2026 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 10, 2026 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Apr 9, 2026 REPR